Paper31350409
A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration.
Handa JT and 8 others. Nat Commun, 2019. Cited by 237 papers, by iCite.
Cite this record
ConductScience Library. A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration. Papers, record 31350409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31350409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Macular Degeneration | Major topic |
| Animals | |
| Humans | |
| Oxidative Stress | |
| Systems Biology |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 EY005722 | NEI NIH HHS | United States | P30EY005722 | PubMed and NIH | NIH RePORTER |
| R01 EY009859 | NEI NIH HHS | United States | R01EY009859 | PubMed and NIH | NIH RePORTER |
| U01 AG032984 | NIA NIH HHS | United States | U01AG032984 | PubMed and NIH | NIH RePORTER |
| R01 EY027691 | NEI NIH HHS | United States | R01EY027691 | PubMed and NIH | NIH RePORTER |
| R42 EY029625 | NEI NIH HHS | United States | R42EY029625 | PubMed and NIH | NIH RePORTER |
| R01 EY026161 | NEI NIH HHS | United States | R01EY026161 | PubMed and NIH | NIH RePORTER |
| R01 AG048927 | NIA NIH HHS | United States | R01AG048927 | PubMed and NIH | NIH RePORTER |
| RF1 AG057519 | NIA NIH HHS | United States | RF1AG057519 | PubMed and NIH | NIH RePORTER |
| P30 EY014104 | NEI NIH HHS | United States | P30EY014104 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05062486 | A Study to Evaluate the Safety and Efficacy of RQC for AMD | Background |
Source ClinicalTrials.gov
References121
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19450445 | A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD. | Exp Eye Res | 2009 | https://conductscience.org/library/papers/19450445 | PubMed |
| 2 | 10814715 | A full genome scan for age-related maculopathy. | Hum Mol Genet | 2000 | https://conductscience.org/library/papers/10814715 | PubMed |
| 3 | 18344451 | Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. | Invest Ophthalmol Vis Sci | 2008 | https://conductscience.org/library/papers/18344451 | PubMed |
| 4 | 8603849 | Oxygen modulates the response of the retinal pigment epithelium to basic fibroblast growth factor and epidermal growth factor by receptor regulation. | Invest Ophthalmol Vis Sci | 1996 | https://conductscience.org/library/papers/8603849 | PubMed |
| 5 | 17021318 | Ranibizumab for neovascular age-related macular degeneration. | N Engl J Med | 2006 | https://conductscience.org/library/papers/17021318 | PubMed |
| 6 | 27287199 | Association of Choroidal Interleukin-17-Producing T Lymphocytes and Macrophages with Geographic Atrophy. | Ophthalmologica | 2016 | https://conductscience.org/library/papers/27287199 | PubMed |
| 7 | 21998696 | Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology. | PLoS One | 2011 | https://conductscience.org/library/papers/21998696 | PubMed |
| 8 | 15761120 | Complement factor H variant increases the risk of age-related macular degeneration. | Science | 2005 | https://conductscience.org/library/papers/15761120 | PubMed |
| 9 | 22930575 | In vivo imaging of photoreceptor disruption associated with age-related macular degeneration: A pilot study. | Lasers Surg Med | 2012 | https://conductscience.org/library/papers/22930575 | PubMed |
| 10 | 24439028 | Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways. | Neurobiol Aging | 2014 | https://conductscience.org/library/papers/24439028 | PubMed |
| 11 | 30124358 | Rise of Deep Learning for Genomic, Proteomic, and Metabolomic Data Integration in Precision Medicine. | OMICS | 2018 | https://conductscience.org/library/papers/30124358 | PubMed |
| 12 | 26923500 | Multi-nucleate retinal pigment epithelium cells of the human macula exhibit a characteristic and highly specific distribution. | Vis Neurosci | 2016 | https://conductscience.org/library/papers/26923500 | PubMed |
| 13 | 17616779 | Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study. | Am J Clin Nutr | 2007 | https://conductscience.org/library/papers/17616779 | PubMed |
| 14 | 15761122 | Complement factor H polymorphism in age-related macular degeneration. | Science | 2005 | https://conductscience.org/library/papers/15761122 | PubMed |
| 15 | 25205867 | Overexpression of HtrA1 and exposure to mainstream cigarette smoke leads to choroidal neovascularization and subretinal deposits in aged mice. | Invest Ophthalmol Vis Sci | 2014 | https://conductscience.org/library/papers/25205867 | PubMed |
| 16 | 24156929 | Phase-variance optical coherence tomography: a technique for noninvasive angiography. | Ophthalmology | 2014 | https://conductscience.org/library/papers/24156929 | PubMed |
| 17 | 23097248 | Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration. | J Pathol | 2013 | https://conductscience.org/library/papers/23097248 | PubMed |
| 18 | 26536825 | Precision medicine for cancer with next-generation functional diagnostics. | Nat Rev Cancer | 2015 | https://conductscience.org/library/papers/26536825 | PubMed |
| 19 | 20238015 | Mitochondrial decay and impairment of antioxidant defenses in aging RPE cells. | Adv Exp Med Biol | 2010 | https://conductscience.org/library/papers/20238015 | PubMed |
| 20 | 19434233 | Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. | PLoS One | 2009 | https://conductscience.org/library/papers/19434233 | PubMed |
Cited by176
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 237 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42723073 | Lipid-driven membrane remodeling engages a lysosome-dependent adaptive repair program during retinal aging. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/42723073 | PubMed |
| 42522009 | Fluorescence lifetimes and choriocapillaris flow deficits in intermediate age-related macular degeneration: a cross-sectional study. | BMC Ophthalmol | 2026 | https://conductscience.org/library/papers/42522009 | PubMed |
| 42484373 | Restoration of impaired lysosomal function mitigates drusen-like deposit formation and cell death in Malattia Leventinese. | JCI Insight | 2026 | https://conductscience.org/library/papers/42484373 | PubMed |
| 42474423 | Macular Metabolism in Young and Older Adults: A Preliminary Optical Coherence Tomography Biomarker Study. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42474423 | PubMed |
| 42465550 | Retinal connections to migraine. | Front Neurol | 2026 | https://conductscience.org/library/papers/42465550 | PubMed |
| 42441062 | Mannose-modified miR-223 nanoparticles remodel pathological microenvironment to suppress inflammation and angiogenesis for neovascular AMD therapy. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42441062 | PubMed |
| 42352019 | Epigenetic-Mitochondrial-Metabolic Crosstalk in Retinal Pigment Epithelium (RPE) Dysfunction in Age-Related Macular Degeneration (AMD). | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42352019 | PubMed |
| 42217724 | Murine models of neovascular AMD revisited: Mechanistic pathways, immune-metabolic crosstalk, and the impact of aging and sex. | Exp Eye Res | 2026 | https://conductscience.org/library/papers/42217724 | PubMed |
| 42198424 | PCSK9 Inhibitor Use and the Risk of Age-Related Macular Degeneration in Patients with Atherosclerotic Cardiovascular Disease. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198424 | PubMed |
| 41974662 | Human retinal organoid model of disease-relevant photoreceptor cell death amenable to drug screening. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41974662 | PubMed |
| 41646411 | Age-Driven Lipid Remodeling Activates Lysosome-Mediated Plasma Membrane Repair. | Res Sq | 2026 | https://conductscience.org/library/papers/41646411 | PubMed |
| 41631752 | CR2-fH, A Targeted Inhibitor of Alternative Complement Pathway Reduces Dry AMD-Like Phenotype in AMD Patient iPSC-derived RPE Cells. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/41631752 | PubMed |
| 41543898 | Molecular underpinnings of induced degenerative heterogeneity in the retinal pigment epithelium. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41543898 | PubMed |
| 41516080 | Integrative Landscape of Dry AMD Pathogenesis, Models, and Emerging Therapeutic Strategies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516080 | PubMed |
| 41511370 | Caffeine Mitigates Adenosine-Mediated Angiogenic Properties of Choroidal Endothelial Cells Through Antagonism of A1 Adenosine Receptor and PI3K-AKT Axis. | Cells | 2026 | https://conductscience.org/library/papers/41511370 | PubMed |
| 41412300 | Prognostic factors for age-related macular degeneration progression: An overview of systematic reviews. | Surv Ophthalmol | 2026 | https://conductscience.org/library/papers/41412300 | PubMed |
| 41123658 | Management of fibrosis in neovascular age-related macular degeneration. | Graefes Arch Clin Exp Ophthalmol | 2026 | https://conductscience.org/library/papers/41123658 | PubMed |
| 41007616 | In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration. | Biomedicines | 2025 | https://conductscience.org/library/papers/41007616 | PubMed |
| 40943530 | CD93 in Health and Disease: Bridging Physiological Functions and Clinical Applications. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943530 | PubMed |
| 40837411 | Human retinal organoids for modelling dry age-related macular degeneration and screening drugs. | Genes Dis | 2025 | https://conductscience.org/library/papers/40837411 | PubMed |
Genes29
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31350409
GET https://conductscience.org/api/papers/v1/31350409/references?page=2